T
TYBR Health
Innovative biomaterial therapies enhancing post-surgery recovery by protecting tendons and ligaments from adhesions and complications
About TYBR Health
TYBR Health is a pioneering company in the field of biomaterial therapeutics, focusing on enhancing post-surgery recovery. The company develops advanced extracellular matrix (ECM) barriers designed to protect tendons and ligaments during the healing process, ensuring a smoother and more efficient recovery. TYBR Health primarily serves orthopedic surgeons and healthcare professionals who value speed, reliability, and cost-effectiveness in post-operative care. Operating in the medical technology market, TYBR Health's business model revolves around the development and commercialization of its ECM barrier products. Revenue is generated through the sale of these innovative biomaterials to hospitals, clinics, and surgical centers. The company's mission is to empower surgeons with tools that help patients reclaim their lives after injury or surgery by simplifying the recovery process through cutting-edge biomaterial solutions.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2020
- Headquarters
- Houston, United States
- Employees
- 21
- Open positions
- None listed
- Dealroom signal
- 91.5/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Surgery, Spinout, Orthopedic, YC W22, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning TYBR Health.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Jul 2026 | $30M | $120M | Mutual Capital Partners · Neovate Capital Partners · Vensana Capital | ↗ |
| OtherOther financing | May 2024 | $0 | — | MedTech Innovator | ↗ |
Growth signals
Latest recorded traffic for TYBR Health is 1.2K monthly website visits, up 22.4% over the last three months. TYBR Health's team grew 110% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Asymmetry Ventures
Y Combinator
Series A3 investors entered at this stage
Mutual Capital Partners
Vensana Capital
Neovate Capital Partners
Other known investors8 additional known investors
Imperial College London
MedTech Innovator
University of Pittsburgh- APAriel Southeast Angel Partners
Creative Destruction Lab
Nucleate
Small Business Innovation Research
VentureSouq
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about TYBR Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See TYBR Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.